Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells

Free Radical Biology and Medicine

Volumn 40, Issue 12, 2006, Pages 2232-2241

  Meiners, Silke ^a   Ludwig, Antje ^a   Lorenz, Mario ^a   Dreger, Henryk ^a   Baumann, Gert ^a   Stangl, Verena ^a   Stangl, Karl ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antioxidative enzymes; Endothelial cell; Oxidative stress; Proteasome; Protection

Indexed keywords

ANTIOXIDANT; ENZYME INHIBITOR; HYDROGEN PEROXIDE; PROTEASOME;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE CONTROL; GENE NUMBER; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION; VASCULAR RING;

ANTIOXIDANTS; APOPTOSIS; BORONIC ACIDS; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; LEUPEPTINS; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION, GENETIC;

EID: 33745227748     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.03.003     Document Type: Article

References (36)

1. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
2. Voges D., Zwickl P., and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68 (1999) 1015-1068
3. Muratani M., and Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell. Biol. 4 (2003) 192-201
4. Naujokat C., and Hoffmann S. Role and function of the 26S proteasome in proliferation and apoptosis. Lab. Invest. 82 (2002) 965-980
5. Voorhees P.M., and Orlowski R.Z. The proteasome and proteasome inhibitors in cancer therapy. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 189-213
6. Meiners S., Laule M., Rother W., Guenther C., Prauka I., Muschick P., Baumann G., Kloetzel P.M., and Stangl K. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation 105 (2002) 483-489
7. Bross P.F., Kane R., Farrell A.T., Abraham S., Benson K., Brower M.E., Bradley S., Gobburu J.V., Goheer A., Lee S.L., Leighton J., Liang C.Y., Lostritto R.T., McGuinn W.D., Morse D.E., Rahman A., Rosario L.A., Verbois S.L., Williams G., Wang Y.C., and Pazdur R. Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin. Cancer Res. 10 (2004) 3954-3964
8. Elliott P.J., Zollner T.M., and Boehncke W.H. Proteasome inhibition: a new anti-inflammatory strategy. J. Mol. Med. 81 (2003) 235-245
9. Wojcik C., and Di Napoli M. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke 35 (2004) 1506-1518
10. Stangl V., Gunther C., Jarrin A., Bramlage P., Moobed M., Staudt A., Baumann G., Stangl K., and Felix S.B. Homocysteine inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion via nuclear factor-kappaB dependent pathway. Biochem. Biophys. Res. Commun. 280 (2001) 1093-1100
11. Bierl C., Voetsch B., Jin R.C., Handy D.E., and Loscalzo J. Determinants of human plasma glutathione peroxidase (GPx-3) expression. J. Biol. Chem. 279 (2004) 26839-26845
12. Rojo A.I., Salinas M., Martin D., Perona R., and Cuadrado A. Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J. Neurosci. 24 (2004) 7324-7334
13. Stangl K., Gunther C., Frank T., Lorenz M., Meiners S., Ropke T., Stelter L., Moobed M., Baumann G., Kloetzel P.M., and Stangl V. Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem. Biophys. Res. Commun. 291 (2002) 542-549
14. Ludwig A., Friedel B., Metzkow S., Meiners S., Stangl V., Baumann G., and Stangl K. Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells. Biochem. Pharmacol. 70 (2005) 520-526
15. Meiners S., Heyken D., Weller A., Ludwig A., Stangl K., Kloetzel P.M., and Kruger E. Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J. Biol. Chem. 278 (2003) 21517-21525
16. Stangl V., Lorenz M., Meiners S., Ludwig A., Bartsch C., Moobed M., Vietzke A., Kinkel H.T., Baumann G., and Stangl K. Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway. FASEB J. 18 (2004) 272-279
17. Kisselev A.F., and Goldberg A.L. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8 (2001) 739-758
18. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., Wakisaka M., Ibayashi S., Utsumi H., and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 (2004) 227-233
19. Mitsiades N., Mitsiades C.S., Poulaki V., Chauhan D., Fanourakis G., Gu X., Bailey C., Joseph M., Libermann T.A., Treon S.P., Munshi N.C., Richardson P.G., Hideshima T., and Anderson K.C. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. USA 99 (2002) 14374-14379
20. Yew E.H., Cheung N.S., Choy M.S., Qi R.Z., Lee A.Y., Peng Z.F., Melendez A.J., Manikandan J., Koay E.S., Chiu L.L., Ng W.L., Whiteman M., Kandiah J., and Halliwell B. Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis. J. Neurochem. 94 (2005) 943-956
21. Mitsiades N., Mitsiades C.S., Richardson P.G., Poulaki V., Tai Y.T., Chauhan D., Fanourakis G., Gu X., Bailey C., Joseph M., Libermann T.A., Schlossman R., Munshi N.C., Hideshima T., and Anderson K.C. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications. Blood 101 (2003) 2377-2380
22. Wei W., Ayad N.G., Wan Y., Zhang G.J., Kirschner M.W., and Kaelin Jr. W.G. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428 (2004) 194-198
23. Bashir T., Dorrello N.V., Amador V., Guardavaccaro D., and Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428 (2004) 190-193
24. Bush K.T., Goldberg A.L., and Nigam S.K. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J. Biol. Chem. 272 (1997) 9086-9092
25. Freedman J.E., Loscalzo J., Benoit S.E., Valeri C.R., Barnard M.R., and Michelson A.D. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J. Clin. Invest. 97 (1996) 979-987
26. Yoshimura S., Suemizu H., Nomoto Y., Sakai H., Katsuoka Y., Kawamura N., and Moriuchi T. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 73 (1996) 207-211
27. Usami H., Kusano Y., Kumagai T., Osada S., Itoh K., Kobayashi A., Yamamoto M., and Uchida K. Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors. J. Biol. Chem. 280 (2005) 25267-25276
28. Wu W.T., Chi K.H., Ho F.M., Tsao W.C., and Lin W.W. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochem. J. 379 (2004) 587-593
29. Yang Y., Yang Y., Trent M.B., He N., Lick S.D., Zimniak P., Awasthi Y.C., and Boor P.J. Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis. Atherosclerosis 173 (2004) 211-221
30. Otterbein L.E., Soares M.P., Yamashita K., and Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24 (2003) 449-455
31. Didion S.P., and Faraci F.M. Ceramide-induced impairment of endothelial function is prevented by CuZn superoxide dismutase overexpression. Arterioscler. Thromb. Vasc. Biol. 25 (2004) 90-95
32. Pohlman T.H., and Harlan J.M. Adaptive responses of the endothelium to stress. J. Surg. Res. 89 (2000) 85-119
33. McCormick S.M., Frye S.R., Eskin S.G., Teng C.L., Lu C.M., Russell C.G., Chittur K.K., and McIntire L.V. Microarray analysis of shear stressed endothelial cells. Biorheology 40 (2003) 5-11
34. Brooks A.R., Lelkes P.I., and Rubanyi G.M. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genomics 9 (2002) 27-41
35. Morikawa S., Takabe W., Mataki C., Wada Y., Izumi A., Saito Y., Hamakubo T., and Kodama T. Global analysis of RNA expression profile in human vascular cells treated with statins. J. Atheroscler. Thromb. 11 (2004) 62-72
36. Ding Q., Bruce-Keller A.J., Chen Q., and Keller J.N. Analysis of gene expression in neuronal cells subject to chronic proteasome inhibition. Free Radical Biol. Med. 36 (2004) 445-455